79.77
전일 마감가:
$78.92
열려 있는:
$78.47
하루 거래량:
5.35M
Relative Volume:
1.02
시가총액:
$33.41B
수익:
$9.51B
순이익/손실:
$2.64B
주가수익비율:
13.22
EPS:
6.0361
순현금흐름:
$2.14B
1주 성능:
+7.19%
1개월 성능:
-35.07%
6개월 성능:
-31.24%
1년 성능:
-51.31%
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ZTS
Zoetis Inc
|
79.69 | 32.58B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.68 | 52.36B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.275 | 40.62B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.32 | 39.63B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
UTHR
United Therapeutics Corp
|
565.65 | 24.07B | 3.17B | 1.29B | 1.01B | 27.09 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
ZTS Investor Alert: Levi & Korsinsky Investigates Zoetis (ZTS) for Potential Securities Fraud - Morningstar
Zoetis Stock Pulls Back to Support – Smart Entry? - Trefis
Barclays (DJP) prices Zoetis‑linked Notes with 13.20% digital payout - Stock Titan
Zoetis Stock Near Crucial SupportBuy Signal? - Trefis
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zoetis, Inc. (ZTS) And Encourages Stockholders to Connect - The National Law Review
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
New FDA Authorization Broadens Zoetis Screwworm Treatment Options - Successful Farming
A Look At Zoetis (ZTS) Valuation After Soft Q1 Results And Lower 2026 Guidance - simplywall.st
Zoetis Inc (NYSE:ZTS): A Dividend Growth Stock with Strong Profitability and Attractive Valuation - ChartMill
Zoetis Q1 earnings lag estimates, 2026 view cut, stock down - MSN
Zoetis Inc (ZTS) Shares Surge 4.7% -- What GF Score of 83 Tells Investors - GuruFocus
Zoetis Price Target Cut to $112.00/Share From $145.00 by Citigroup - Moomoo
Zoetis: Reducing Our Fair Value Estimate, but Shares Remain Undervalued - Morningstar
FinancialContentZoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - FinancialContent
Zoetis' Wide Moat Remains Intact, but We've Lowered Our Fair Value Estimate - Morningstar
Citigroup Adjusts Price Target on Zoetis to $112 From $145, Maintains Buy Rating - Moomoo
Why Zoetis (ZTS) Is Down 10.4% After Trimming 2026 Outlook Amid Weaker Pet Demand - simplywall.st
Zoetis Inc. stock underperforms Monday when compared to competitors - MSN
5 Revealing Analyst Questions From Zoetis’s Q1 Earnings Call - Yahoo Finance
Stoneridge Investment Partners LLC Makes New Investment in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Shares Sold by Saratoga Research & Investment Management - MarketBeat
Zoetis Inc. $ZTS Shares Bought by Canada Post Corp Registered Pension Plan - MarketBeat
(ZTS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Zoetis Drops to 52-Week Low, Monday Open in Focus - TechStock²
Zoetis Stock at Support Zone – Bargain or Trap? - Trefis
Zoetis (ZTS) Valuation Reset After Q1 Earnings Miss And Guidance Cut - Yahoo Finance
Marathon, Coherent, Senseonics, KLA, Zoetis Insider Shakeup - TipRanks
Zoetis Stock Hits Key SupportBuying Opportunity? - Trefis
Novare Capital Management LLC Trims Stake in Zoetis Inc. $ZTS - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Atria Investments Inc Sells 24,176 Shares of Zoetis Inc. $ZTS - MarketBeat
Securities Fraud Investigation Into Zoetis Inc. (ZTS) Announced – - The National Law Review
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
Morgan Stanley Adjusts Price Target on Zoetis to $115 From $160, Maintains Overweight Rating - Moomoo
Morgan Stanley Maintains Zoetis(ZTS.US) With Buy Rating, Cuts Target Price to $75.48 - Moomoo
Zoetis Inc. Stock 12‑Month Price Target Cut to $126.07, Implies 67% Upside - TradingView
Zoetis, Inc. Stock Plummets to New 52-Week Low of $85.33 - Markets Mojo
Why S&P 500 Attention Is Turning Toward Zoetis Growth? - Kalkine Media
Zoetis stock hits 52-week low at $74.29 amid market fluctuations - Investing.com
Jim Cramer Calls Zoetis a “Quality Company” Despite Recent Declines - Insider Monkey
Zoetis shares plunge 21.5% after slashing 2026 revenue guidance amid pet-care demand slowdown - Pluang
ZTS SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Zoetis for Possible Securities Law Violations - GlobeNewswire
Here is Why Zoetis (ZTS) is One of the Best NYSE Stocks According Analysts - Yahoo Finance
Zoetis (ZTS) Securities Fraud InvestigationLevi & Korsinsky - Sahm
Pacer Advisors Inc. Raises Stake in Zoetis Inc. $ZTS - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Sells 13,580 Shares of Zoetis Inc. $ZTS - MarketBeat
ZTS Technical Analysis | Trend, Signals & Chart Patterns | ZOETIS INC (NYSE:ZTS) - ChartMill
Insider Buying: Frank Damelio Acquires Shares of Zoetis Inc (ZTS) - GuruFocus
Zoetis director Frank A. Damelio buys $501,343 in company stock By Investing.com - Investing.com South Africa
Zoetis director Paul Bisaro purchases $151,750 in ZTS stock By Investing.com - Investing.com Nigeria
Zoetis director Paul Bisaro purchases $151,750 in ZTS stock - Investing.com
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):